First single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO Guidelines – GSK
GSK plc and Medicines for Malaria Venture (MMV) announced that the World Health Organization (WHO) has awarded prequalification to tafenoquine, the first single-dose medicine for the prevention of… read more.
